Transcept (TSPT) Reports New Dosages of Intermezzo Available for Prescription

Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) reports that Intermezzo (zolpidem tartrate) sublingual tablet CIV is now available by prescription in 1.75 mg and 3.5 mg dosage strengths in retail pharmacies nationwide. Intermezzo is the first and only prescription sleep aid approved for middle-of-the-night dosing, and should only be taken once per night in bed, as needed, when a patient wakes up in the middle of the night and has difficulty returning to sleep. Intermezzo is not indicated for use when a patient has fewer than four hours of bedtime remaining before the planned time of waking.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• FDA authorizes 11 ZYN Ultra nicotine pouches for Philip Morris
• Nuvectis Pharma (NVCT) files $200M mixed shelf
• loanDepot receives NYSE non-compliance notice over stock price